These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16621968)

  • 1. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System.
    Tomosugi N; Kawabata H; Wakatabe R; Higuchi M; Yamaya H; Umehara H; Ishikawa I
    Blood; 2006 Aug; 108(4):1381-7. PubMed ID: 16621968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.
    Kemna EH; Tjalsma H; Podust VN; Swinkels DW
    Clin Chem; 2007 Apr; 53(4):620-8. PubMed ID: 17272487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.
    Campostrini N; Castagna A; Zaninotto F; Bedogna V; Tessitore N; Poli A; Martinelli N; Lupo A; Olivieri O; Girelli D
    J Biomed Biotechnol; 2010; 2010():329646. PubMed ID: 20414466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin assay in serum by SELDI-TOF-MS and other approaches.
    Castagna A; Campostrini N; Zaninotto F; Girelli D
    J Proteomics; 2010 Jan; 73(3):527-36. PubMed ID: 19683083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI-TOF MS detection of urinary hepcidin.
    Altamura S; Kiss J; Blattmann C; Gilles W; Muckenthaler MU
    Biochimie; 2009 Oct; 91(10):1335-8. PubMed ID: 19393287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel urine hepcidin assay by mass spectrometry.
    Kemna E; Tjalsma H; Laarakkers C; Nemeth E; Willems H; Swinkels D
    Blood; 2005 Nov; 106(9):3268-70. PubMed ID: 16030189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of iron metabolism-regulator hepcidin in perinatal iron homeostasis].
    Balogh A; Bosze S; Horváti K; Mezo G; Kéki S; Nagy L; Bokodi G; Szabó M; Vásárhelyi B
    Orv Hetil; 2010 Jan; 151(3):83-91. PubMed ID: 20061265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
    van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Gaillard CA; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
    PLoS One; 2012; 7(7):e39783. PubMed ID: 22808058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.
    Kroot JJ; Laarakkers CM; Geurts-Moespot AJ; Grebenchtchikov N; Pickkers P; van Ede AE; Peters HP; van Dongen-Lases E; Wetzels JF; Sweep FC; Tjalsma H; Swinkels DW
    Clin Chem; 2010 Oct; 56(10):1570-9. PubMed ID: 20739637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method.
    Hwang SI; Lee YY; Park JO; Norton HJ; Clemens E; Schrum LW; Bonkovsky HL
    Clin Chim Acta; 2011 Nov; 412(23-24):2241-7. PubMed ID: 21867695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study.
    Ho J; Lucy M; Krokhin O; Hayglass K; Pascoe E; Darroch G; Rush D; Nickerson P; Rigatto C; Reslerova M
    Am J Kidney Dis; 2009 Apr; 53(4):584-95. PubMed ID: 19070948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
    Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
    Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA.
    Peters HP; Rumjon A; Bansal SS; Laarakkers CM; van den Brand JA; Sarafidis P; Musto R; Malyszko J; Swinkels DW; Wetzels JF; Macdougall IC
    Nephrol Dial Transplant; 2012 Oct; 27(10):3923-9. PubMed ID: 22815544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.
    Nemeth E; Valore EV; Territo M; Schiller G; Lichtenstein A; Ganz T
    Blood; 2003 Apr; 101(7):2461-3. PubMed ID: 12433676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anemia of ageing is not associated with increased plasma hepcidin levels.
    Lee P; Gelbart T; Waalen J; Beutler E
    Blood Cells Mol Dis; 2008; 41(3):252-4. PubMed ID: 18676162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
    Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
    J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.
    Matsumoto M; Tsujino T; Lee-Kawabata M; Naito Y; Akahori H; Sakoda T; Ohyanagi M; Tomosugi N; Masuyama T
    Circ J; 2010 Feb; 74(2):301-6. PubMed ID: 20019408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.